Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Toni

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
European Stroke Journal|February 18, 2021
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after strokeManuel Cappellari, David J Seiffge, Masatoshi Koga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 8, 2017
Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysisAnna Maria Gori, Betti Giusti, Benedetta Piccardi, et al.
Frontiers in Neurology|June 16, 2015
Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC StudyBenedetta Piccardi, Vanessa Palumbo, Mascia Nesi, et al.
The New England Journal of Medicine|May 16, 2019
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Journal of the American Heart Association|February 20, 2026
Mothership Versus Drip-and-Ship Models in Acute Stroke Care: A Time-Sensitive Meta-AnalysisLucio D'Anna, Lorenzo Barba, Samir Abu-Rumeileh, et al.
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Journal of Anesthesia, Analgesia and Critical Care|May 9, 2025
Golden hour management in the patient with intraparenchymal cerebral hemorrhage: an Italian intersociety documentGianluigi Morello, Daniela Alampi, Raffaele Aspide, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
European Stroke Journal|February 18, 2021
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after strokeManuel Cappellari, David J Seiffge, Masatoshi Koga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 8, 2017
Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysisAnna Maria Gori, Betti Giusti, Benedetta Piccardi, et al.
Frontiers in Neurology|June 16, 2015
Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC StudyBenedetta Piccardi, Vanessa Palumbo, Mascia Nesi, et al.
The New England Journal of Medicine|May 16, 2019
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Journal of the American Heart Association|February 20, 2026
Mothership Versus Drip-and-Ship Models in Acute Stroke Care: A Time-Sensitive Meta-AnalysisLucio D'Anna, Lorenzo Barba, Samir Abu-Rumeileh, et al.
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Journal of Anesthesia, Analgesia and Critical Care|May 9, 2025
Golden hour management in the patient with intraparenchymal cerebral hemorrhage: an Italian intersociety documentGianluigi Morello, Daniela Alampi, Raffaele Aspide, et al.
Pageof 26